0000814133-25-000017.txt : 20250211
0000814133-25-000017.hdr.sgml : 20250211
20250211173712
ACCESSION NUMBER: 0000814133-25-000017
CONFORMED SUBMISSION TYPE: SCHEDULE 13G
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20250211
DATE AS OF CHANGE: 20250211
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: MACROGENICS INC
CENTRAL INDEX KEY: 0001125345
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: SCHEDULE 13G
SEC ACT: 1934 Act
SEC FILE NUMBER: 005-87928
FILM NUMBER: 25611049
BUSINESS ADDRESS:
STREET 1: 9704 MEDICAL CENTER DRIVE
CITY: Rockville
STATE: MD
ZIP: 20850
BUSINESS PHONE: 301-251-5172
MAIL ADDRESS:
STREET 1: 9704 MEDICAL CENTER DRIVE
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: WASATCH ADVISORS LP
CENTRAL INDEX KEY: 0000814133
ORGANIZATION NAME:
IRS NUMBER: 870319391
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: SCHEDULE 13G
BUSINESS ADDRESS:
STREET 1: 505 WAKARA WAY
STREET 2: 3RD FLOOR
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84108
BUSINESS PHONE: 8015330777
MAIL ADDRESS:
STREET 1: 505 WAKARA WAY
STREET 2: 3RD FLOOR
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84108
FORMER COMPANY:
FORMER CONFORMED NAME: WASATCH ADVISORS INC
DATE OF NAME CHANGE: 19990611
SCHEDULE 13G
1
primary_doc.xml
SCHEDULE 13G
0000814133
XXXXXXXX
LIVE
Common Stock
12/31/2024
0001125345
MACROGENICS INC
556099109
9704 MEDICAL CENTER DRIVE
Rockville
MD
20850
Rule 13d-1(b)
WASATCH ADVISORS LP
a
DE
3488493.00
0.00
3488493.00
0.00
3488493.00
5.6
IA
MACROGENICS INC
9704 MEDICAL CENTER DRIVE, Rockville, MARYLAND, 20850
Wasatch Advisors LP
505 Wakara Way, 3rd Floor, Salt Lake City, 84108, United States
Delaware
N
IA
3,488,493
5.6
3,488,493
0
3,488,493
0
Y
N
Y
Y
Y
Y
N
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
WASATCH ADVISORS LP
Mike Yeates
CEO
02/11/2025